Hao Zhan

Dr. Zhan Hao has been practicing law for more than 20 years. He has extensive knowledge and experience in the areas of insurance & reinsurance and litigation & arbitration.

Dr. Zhan Hao has been consecutively ranked for more than 10 years by Chambers & Partners as Band 1 China'Insurance & Reinsurance Lawyer in recognizing his high level of expertise and diligence. The team led by Dr. Zhan Hao is one of the largest, most well-rounded and influential insurance legal teams in China.

Representative Cases

Insurance & Reinsurance

• Dr. Zhan Hao is widely recognized for his representative work, which includes: litigation and arbitration concerning insurance claims, subrogation and reinsurance, M&A relating to insurance companies, establishment of domestic and foreign insurance organizations in the PRC, utilization of insurance funds, compliance with insurance regulations, review of insurance products, extended warranty, corporate governance, and subordinated debt issuance, CAT bond insurance, and IPOs for insurance companies.

• As an industry-leading insurance lawyer, Dr. Zhan Hao provides legal services for domestic insurance organizations and insurance asset management companies (AMC) in their utilization of insurance funds, investment, and financing (this includes using insurance funds to make PE investments, investments in infrastructure, investments in real estate, subordinated debt issuances, and IPO's, among other such investment and financing transactions). In addition, he advises several Chinese insurance companies on their investments in the United States, Korea, Japan, Australia and Europe. For example, Dr. Zhan Hao represented a domestic insurance broker in providing packaged services for its private equity, attracting investors, purchasing equity in insurance companies for a bank, conducting due diligence, and providing equity-transfer services for a Japanese company and an integrated financing group in their purchase of the domestic insurer's shares.

• Additionally, Dr. Zhan Hao establishes annuity trusteeships for central government-sponsored enterprises and listed enterprises. He also acts as a legal counsel for insurance & reinsurance companies, AMCs, insurance brokers and foreign insurance companies over policy review, corporate compliance, and development of new insurance products, among other services. For instance, he acted as a legal counsel for a PRC reinsurer to issue the first CAT Bond in the US.

• Dr. Zhan Hao has a wide breadth of experience in litigations and arbitrations related to insurance. He handles litigation and arbitration matters concerning insurance claim and subrogation in construction insurance, marine insurance, D&O, property insurance, pollution liability insurance, and product liability insurance.

• Currently, AnJie Broad's full-service insurance team led by Dr. Zhan is one of the biggest and most influential insurance teams among law firms in China.

Antitrust/Competition

• As a top antitrust lawyer in China, Dr. Zhan Hao has handled a large number of cases in antitrust civil litigation, antitrust investigations, notifications for concentrations of undertakings and antitrust compliance.

• Dr. Zhan Hao handles many civil antitrust lawsuits involving significant amounts of money and complex fact patterns, including litigation cases which involves complex areas such as standard essential patents, refusal to deal, monopoly price maintenance, platform markets, and other like matters. By way of example, he represented state-owned oil companies SINOPEC in the first China Petroleum antitrust case and prevailed. He also represented a world-renowned electronics company in a vertical monopoly case and prevailed.

• He also provides merger filings for American, German, Australian, Canadian, Japanese, Korean, Indian and Chinese enterprises in a broad range of sectors, including petrochemical, aviation, semiconductor, automotive, finance, pharmaceutical, investment funds, entertainment, machinery, IT, mining, food, pharmacy, energy, financing, telecommunicating and other industries. For example, he assisted a client in successfully obtaining antitrust review approval in the acquisition of Syngenta by ChemChina, which amounts to $4.3 billion and is the largest antitrust filing in China to date.

• Dr Zhan Hao defends enterprises against antitrust investigations commenced by antitrust enforcement agencies and advises well-known companies on how to respond to inquiries from antitrust authorities. For instance, he responded to China's first price cartel investigation on behalf of client, which resulted in the termination of the investigation; he also assisted clients in obtaining a mitigated fine in the first antitrust enforcement case in China.

• Furthermore, Dr Zhan Hao assists Chinese enterprises file concentration reviews for their M&A in EU countries, America, Australia, Japan, Canada and South Korea. He also assists foreign companies with security reviews for mergers in China.

Litigation and Arbitration

• Dr. Zhan Hao handles many major, complicated cases. His litigation experience includes handling appellate litigation before the Supreme People's Court, and which in some cases were selected for publication as Guiding Cases of the Supreme People's Court.

• Also, Dr. Zhan Hao acts as legal counsel for numerous arbitration cases within the PRC (Hong Kong and Mainland), the UK, France, Singapore, Stockholm and Japan, among other jurisdictions, and helps foreign clients to get foreign arbitrary awards recognized and enforced in the PRC.

Honors & Recognition

Insurance & Reinsurance

• Band 1 Lawyer in Insurance of China — Chambers & Partners, 2009-2024

• “Hall of Fame” in Insurance —The Legal 500, 2022-2024

• Leading Individual in Insurance — The Legal 500, 2020-2024

• Insurance Industry Star — LEGALBAND, 2019-2024

• Outstanding Lawyer in Insurance — Asialaw Profiles, 2020-2023

• Global Best Insurance and Reinsurance Lawyer — Who's Who Legal, 2010-2022

• China's Best Insurance Lawyer — PLC Which Lawyer, 2010-2017

• Best Lawyer, Insurance Industry (China) — Expert Guide, 2010-2017

Litigation & Arbitration

• “Litigation Star” in Commercial Disputes — Benchmark Litigation, 2022-2024

• Highly Recommended Lawyer in Dispute Resolution: Arbitration — The Legal 500, 2022

• Commercial Dispute Litigation Star - Benchmark Litigation, 2022

• Dispute Resolution Star — Benchmark Litigation, 2019

• China's Top 10 Most Influential Litigation Lawyers — Asian Legal Business, 2013-2016

• China's Dispute Resolution Lawyers — Benchmark Litigation, 2013-2014

Competition/Antitrust

• Tier 1 PRC Competition/Antitrust Lawyer, Chambers & Partner, 2019-2024

• Recommended Antitrust Lawyer, LEGALBAND, 2015-2024

• Recommended Antitrust Lawyer, Legal 500, 2017, 2019-2022

• Leading Antitrust Lawyer, Who's Who Legal, 2011-2022

• Top 10 Antitrust Lawyer, China Intellectual Property Forum, 2019-2023

• Leading Antitrust Lawyer, Asialaw, 2015, 2016, 2019, 2020

Other

• “Managing Partner of the Year” — LEGALBAND, 2023-2024

• The A-List Legal Elite — China Business Law Journal, 2019-2023

• Annual Recommendation of External Counsel — In-House Community, 2020

• China's Top 20 Client Choice Lawyers — Asian Legal Business, 2013-2015

Professional Association

• Member, Expert Committee of the Supreme People's Procuratorate on the supervision of civil and administrative litigation

• Chinese regional ambassador and Deputy chairman of ICC China Competition Commission

• Vice President of Beijing Digital Economy and Digital Governance Research Association

• Antitrust legal expert for Shandong AMR and others

• Arbitrator, CIETAC

• Arbitrator, BAC

• Arbitrator, SHIAC

• Arbitrator, SCIA

• Arbitrator, HKIAC

• Arbitrator, KLRCA

• Arbitrator, Hainan International Arbitration Court

• Arbitrator, Harbin Arbitration Commission

• Arbitrator, Nanjing Arbitration Commission

• Arbitrator, Chongqing Arbitration Commission

• Arbitrator, Wenzhou Arbitration Commission

• Arbitrator, Taizhou Arbitration Commission

• Arbitrator, Wuhan Arbitration Commission

• Arbitrator, Ningbo Arbitration Commission

• Arbitrator, China Chongqing Liangjiang International Arbitration Center

• Vice President, National Lawyers Association Financial Insurance Commission

• Member, American International Commercial Arbitration Court (“AICAC”)

• Member, London Court of International Arbitration (Asia Pacific)

• Commissioner, Legal Advisory Board of All-China Federation of Returned Overseas Chinese

• Vice Director, Vehicle Insurance Expert Committee, Insurance Association of China

• Member, Insurance Lawyers Group, Insurance Association of China

• Member, Legal Professional Committee, Insurance Society of China

• Member, IAMAC Legal and Compliance Committee

• Expert, IAMAC Legal Experts Database

• Outstanding Expert, IAMAC Registration and Assessment of Debt Investment

• Master of Law Instructor, Central University of Finance & Economics School of Law, Renmin University School of Law

Publications

• The Insurance & Reinsurance Law Review (China Chapter), Law Business Research, 2017-2024

• The lnternational Arbitration Review (China Chapter), Law Business Research, 2022-2024

• Insurance & Reinsurance (Q&A+T&D), Chambers and Partners, 2024

• Getting the Deal Through Complex Commercial Litigation (China Chapter), Law Business Research, 2020-2023

• Getting the Deal Through Insurance Litigation (China Chapter), Law Business Research, 2014-2023

• Complete Collection of Court Rulings in China Insurance Litigation——Compilation and Logical Classification of Classic Judgments of Insurance Litigation, Law Press, 2019

• Analysis on New Insurance Cases, Law Press, 2016

• China Motor Vehicle Insurance Market Development Report 2014 (co-author), China Insurance Industry Association, 2015

• Detailed Explanation of Hot Topics and Cases of New Insurance Law, Law Press, 2010

• Records on the Course of Case-Handling by Chinese Lawyers——Insurance Litigation, Law Press, 2008

• Economic Law Analysis of Insurance Market Regulation, China Legal Press, 2007

• Essential Principles, Comments & Analysis of Typical Cases in Insurance Law, China Legal Press, 2007